Advertisement
PerkinElmer
PerkinElmer

The Scientist

» human trial

Most Recent

image: Ebola Drug Trial Terminated

Ebola Drug Trial Terminated

By | June 23, 2015

Early analysis of TKM-Ebola-Guinea offers discouraging results, causing sponsors to end the Phase 2 trial.

0 Comments

image: Ebola Vax Trial Update

Ebola Vax Trial Update

By | March 26, 2015

A novel Ebola vaccine being tested in China is safe and provokes a notable immune response in people, according to a Phase 1 trial.

0 Comments

image: Ebola Update

Ebola Update

By | January 26, 2015

Vaccine trial to start in Liberia as early as next week; trial for experimental therapy also planned, but production is still limited

1 Comment

image: NIH To Speed Ebola Vax Trials

NIH To Speed Ebola Vax Trials

By | September 2, 2014

The ongoing Ebola outbreak has prompted the National Institutes of Health to accelerate human trials of multiple Ebola vaccines, starting this week.

0 Comments

image: Ovarian Cancer Screen Shows Promise

Ovarian Cancer Screen Shows Promise

By | August 27, 2013

A blood test for the protein CA-125, coupled with a vaginal ultrasound, can help detect the difficult-to-spot cancer.

0 Comments

image: Stem Cell Trial Nearly Approved

Stem Cell Trial Nearly Approved

By | February 15, 2013

The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.

0 Comments

image: Eye Trials Give Hope for Stem Cells

Eye Trials Give Hope for Stem Cells

By | January 24, 2012

Preliminary data from human embryonic stem cell trials for two degenerative eye disorders are promising, but challenges remain for more complex tissues.

9 Comments

Advertisement

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
Bina Technologies
Bina Technologies
Advertisement
The Scientist